SCHEMBL10282916

SCHEMBL10282916

NC1CCN(C(=O)c2ccc3ccccc3c2)CC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.74
RAB9A P51151 1/20 0.74
TSHR P16473 2/20 0.64
HPGD P15428 1/20 0.64
AKR1C1 Q04828 1/20 0.62
LMNA P02545 2/20 0.61
DRD4 P21917 3/20 0.61
CA12 O43570 1/20 0.60
CA1 P00915 1/20 0.60
CA2 P00918 1/20 0.60
CA7 P43166 1/20 0.60
CA9 Q16790 1/20 0.60
L3MBTL3 Q96JM7 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
DPP4 P27487 1/20 0.57
DPP8 Q6V1X1 1/20 0.57
USP2 O75604 1/20 0.57
ALDH1A1 P00352 1/20 0.57
GAA P10253 1/20 0.57
MAPT P10636 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4618408 0.98 NPC1 (0.72) NPC1RAB9ATSHRHPGDAKR1C1
SCHEMBL5392782 0.91 NPC1 (0.66) NPC1RAB9ATSHRHPGDAKR1C1
SCHEMBL4310722 0.85 TSHR (0.84) NPC1RAB9ATSHRHPGDAKR1C1
SCHEMBL7302754 0.84 NPC1 (0.72) NPC1RAB9ATSHRHPGDAKR1C1
SCHEMBL27297526 0.82 NPC1 (0.70) NPC1RAB9ATSHRHPGDAKR1C1
SCHEMBL7218802 0.82 HPGD (0.73) NPC1RAB9ATSHRHPGDAKR1C1
SCHEMBL1136719 0.82 L3MBTL3 (0.59) HPGDCA12CA1CA2CA7
SCHEMBL9193006 0.81 TSHR (0.72) NPC1RAB9ATSHRHPGDAKR1C1
SCHEMBL11986399 0.81 NPC1 (0.72) NPC1RAB9ATSHRHPGDAKR1C1
SCHEMBL408393 0.81 NPC1 (0.72) NPC1RAB9ATSHRHPGDAKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120009151-A1 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof PROGENICS PHARMACEUTICALS, INC. (US) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120009151-A1 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof HAVCR2, ZC3HAV1, MAVS NPC1 196/4885RAB9A 2965/4885TSHR 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.